Literature DB >> 12505950

Catheter-associated masses in patients receiving intrathecal analgesic therapy.

Marion R McMillan1, Thomas Doud, W Nugent.   

Abstract

UNLABELLED: A cohort of seven patients receiving intrathecal analgesic drug therapy for chronic intractable pain underwent radiocontrast myelography and computed tomography (CT) scanning to screen for catheter-associated intrathecal masses. Three of seven patients examined had intraspinal masses associated with the tip of the drug infusion catheter after a total of 118 mo of therapy. The index case presented with exacerbation of neuropathic pain and paralysis of the left lower extremity. The two additional cases detected by CT myelography were asymptomatic at the time the catheter-associated mass was assessed. The mean duration of therapy before diagnosis of the catheter-associated mass was 19.6 mo, with a range of 16-25 mo. An intergroup comparison of demographic and treatment variables between patients, with and without catheter-associated masses, demonstrated that patients with masses were younger and were receiving a larger morphine dose than patients without masses. The differences were statistically significant (P = 0.05). In one patient with an asymptomatic catheter-associated intrathecal mass, regression of the mass was observed after cessation of therapy. In a second asymptomatic patient, the mass remained stable over 1 yr of continued treatment after substitution of hydromorphone for morphine without interruption of therapy. Neither asymptomatic patient has subsequently developed additional neurologic findings or injury after detection of occult catheter-associated intrathecal masses and clinical intervention. We suggest that all patients receiving long-term intrathecal analgesia should undergo periodic radiographic surveillance to further define their risk of developing occult catheter-associated masses and to allow intervention before neurologic injury can develop. IMPLICATIONS: Catheter-associated intrathecal masses were detected in three of seven patients receiving long-term intrathecal analgesia. In the two asymptomatic patients, timely clinical intervention was associated with the avoidance of subsequent neurologic injury and spontaneous resolution of one of the occult masses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505950     DOI: 10.1097/00000539-200301000-00039

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  10 in total

1.  Intrathecal catheter tip inflammatory mass lesions (granulomas): a case report with bone destruction and review of imaging findings.

Authors:  Beril Gok; Mohammadreza Hayeri; Richard Kanoff; Michael Brooks
Journal:  Emerg Radiol       Date:  2012-07-06

2.  Characteristics of distribution of morphine and metabolites in cerebrospinal fluid and plasma with chronic intrathecal morphine infusion in humans.

Authors:  Mark Wallace; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-19       Impact factor: 5.108

3.  Validation of a preclinical spinal safety model: effects of intrathecal morphine in the neonatal rat.

Authors:  B David Westin; Suellen M Walker; Ronald Deumens; Marjorie Grafe; Tony L Yaksh
Journal:  Anesthesiology       Date:  2010-07       Impact factor: 7.892

Review 4.  [Importance of intrathecal pain therapy].

Authors:  R Likar; W Ilias; H Kloimstein; A Kofler; H G Kress; J Neuhold; M M Pinter; M C Spendel
Journal:  Schmerz       Date:  2007-02       Impact factor: 1.107

5.  Spinal MR findings in continuous epidural analgesia without infection.

Authors:  Ichiro Ikushima; Toshinori Hirai; Yukunori Korogi; Maeda Norio; Mikako Koganemaru; Ryoko Suga; Shoji Morishita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

6.  [Risk assessment in pain therapy].

Authors:  D Schoeffel; H R Casser; M Bach; H G Kress; R Likar; H Locher; W Steinleitner; M Strohmeier; H Brunner; R D Treede; W Zieglgänsberger; J Sandkühler
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

7.  A Patient with an Intradural Tumor: An Unexpected Finding.

Authors:  Devang Padalia; Allan R Escher; Nasrin N Aldawoodi; Neal Shah
Journal:  Cureus       Date:  2020-03-23

Review 8.  Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data.

Authors:  Suellen M Walker; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

9.  Intrathecal catheter-associated inflammatory mass in a neurofibromatosis type-1 patient receiving fentanyl and bupivacaine.

Authors:  Derek G Southwell; Joseph A Osorio; Christopher S Liverman; Lauren M Friedman; Ramana K Naidu; Lawrence R Poree; Melanie M Henry; Line Jacques
Journal:  Surg Neurol Int       Date:  2017-07-25

10.  Spinal cord compression secondary to intrathecal catheter-induced granuloma: a report of four cases.

Authors:  Paul M Arnold; Viraat Harsh; Seth M Oliphant
Journal:  Evid Based Spine Care J       Date:  2011-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.